glp-1 drugs tirzepatide Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with among patients with type 2 diabetes, a large retrospective cohort Comparing Ozempic, Wegovy and Other

Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial

Recent Studies Linking Ozempic to Gastroparesis April 2025: A study called Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy a retrospective cohort study examined if people taking GLP-1 drugs like Ozempic had a higher risk of gastroparesis than people taking another weight-loss drug called bupropion-naltrexone and a treatment called a sleeve gastrectomy

GLP-1 drugs like semaglutide are used to treat Type 2 diabetes and support weight loss

Further research must be conducted to understand the effects of semaglutide on cancer as it belongs to the GLP-1R family along with liraglutide and exendin and may provide similar results

Politics1 year ago Breaking Down the $524 Billion Investment Needed to Rebuild Ukraine Ukraine will require an estimated $524B over the next decade to recover from the Russia-Ukraine war